ETF PROAI
BISProSharesINDEX

ProShares UltraShort Nasdaq Biotechnology

$11.71+0.64% vs prior close
10.532552-WK

Price through Oct 2 · Flows through Oct 2. Figures use the latest available records, not a live quote. Fund details retrieved Oct 2. Holdings snapshot retrieved Oct 2.

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Price & daily flows
21.517.5313.54Mon Sep 28 · Goldman Sachs puts $100 billion Treasury fund on Lynq for crypto firmsThu Sep 24 · Seven UK banks move real money across a shared tokenized railThu Sep 24 · Washington's stablecoin export plan is a Treasury-demand programWed Sep 23 · Korea's tokenization MOU is a seat, not a productThu Sep 10 · A national bank's stablecoin lands on Stellar, freeze switch included11.71DAILY NET FLOWOct 2Feb 2Jun 2Oct 2

SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 3Y SHOWN · NET +$378 OVER THIS RANGE

The desk’s read

Flows are quiet — the past month netted out near zero, while the price has returned -38.2% so far this year. At 0.95% a year it is not the cheapest way in — GSIG has a reported fee of 0.14%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$1928.56Tassets under management
0.95%expense ratio · $95 per $10,000 a year
—net flow, trailing month
8Kavg daily volume, 30 days
7holdings · US-domiciled
2010listed April 9, 2010 · beta -1.51
Sector weights
Cash & Others100%
Cash100%
Other100%
PORTFOLIO COMPOSITION, LATEST DISCLOSURE
Country weights
United States100%
Other100%
Cash56.35%
PORTFOLIO COMPOSITION, LATEST DISCLOSURE
Performance
1 week+4.0%
1 month+8.3%
3 months-8.4%
6 months-33.7%
YTD-38.2%
1 year-52.3%
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week—
1 month—
3 months—
YTD+$460
1 year+$2K

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

Monthly net flows
NovDecJanFebMarAprMayJunJulAugSepOct
DAILY CREATION/REDEMPTION RECORDS, TRAILING TWELVE MONTHS
The risk read
39%realized volatility, 30 days (annualized)
44%realized volatility, 1 year
-57.1%deepest fall from a peak, 1 year
-52.3%latest close versus that peak

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
—calls · latest snapshot
—puts · latest snapshot
—put/call ratio
4Kshares traded
The case against BIS

Due diligence cuts both ways. These funds sit on the same shelf and beat BIS on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
IVV iShares Core S&P 500 ETF0.03%$882.6B+$4.6B-92bp on fee · +$4.6B in over the monthHead-to-head
BBUS JPMorgan BetaBuilders U.S. Equity ETF0.02%$9.4B+$187M-93bp on fee · +$187M in over the monthHead-to-head
STIP iShares 0-5 Year TIPS Bond ETF0.03%$16.3B+$489M-92bp on fee · +$489M in over the monthHead-to-head
SPYG State Street SPDR Portfolio S&P 500 Growth ETF0.04%$56.2B+$717M-91bp on fee · +$717M in over the monthHead-to-head
SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF0.03%$14.1B+$235M-92bp on fee · +$235M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.
InstrumentsHarvest substitutesTrade cost at $1MClient tearsheetStress this fund
THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.